Patents by Inventor Krishna Juluri

Krishna Juluri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240044961
    Abstract: Methods, systems, and/or devices for tuning the configuration settings of one or more RF apparatuses are provided. Various embodiments described herein regard a system that includes a radio frequency apparatus configured to operate based on a plurality of possible configuration settings to generate an output signal that is characterized by a performance metric. The system can also include a tuner that employs a machine learning engine having a training stage and an inference stage. The inference stage can be configured to, based on a machine learning model, search the possible configuration settings for a target configuration setting that results in the performance metric meeting defined bounds of an optimization threshold value.
    Type: Application
    Filed: August 4, 2022
    Publication date: February 8, 2024
    Inventors: Bala Krishna JULURI, Andrew S. CHIKA, Justin M. HALLAS, Timothy M. BECK
  • Publication number: 20160160364
    Abstract: The present disclosure provides a photocatalyst that can utilize plasmon resonance based, near-perfect optical absorption for performing and enhancing photocatalytic reactions. The photocatalyst comprises a substrate and a reflective layer adjacent to the substrate. The reflective layer is configured to reflect light. The photocatalyst further comprises a spacer layer adjacent to the reflective layer. The spacer layer is formed of a semiconductor material or insulator and is at least partially transparent to light. A nanocomposite layer adjacent to the spacer layer is formed of a particles embedded in a matrix. The matrix can comprise a semiconductor, insulator or in some cases metallic pores. The particles can be metallic. Upon exposure to light, the particles can absorb far field electromagnetic radiation and excite plasmon resonances that interact with the reflective layer to form electromagnetic resonances.
    Type: Application
    Filed: October 6, 2015
    Publication date: June 9, 2016
    Inventors: Bala Krishna Juluri, Shawn Meade, Phillip J. Layton
  • Publication number: 20140318596
    Abstract: A system for collecting electromagnetic energy is provided. The system can include one or more electromagnetic energy collection devices. An individual device comprises a first electrically conductive layer adjacent to a semiconductor layer. The first electrically conductive layer forms a Schottky barrier to charge flow at an interface between the first electrically conductive layer and the semiconductor layer. A second electrically conductive layer is disposed adjacent to the semiconductor layer and away from the first electrically conductive layer. The second electrically conductive layer forms an ohmic contact with the semiconductor layer. Upon exposure of the device to electromagnetic energy, the first electrically conductive layer generates localized surface plasmon resonances that resonantly interact with the second electrically conductive layer, providing near perfect absorption of light.
    Type: Application
    Filed: November 13, 2012
    Publication date: October 30, 2014
    Inventors: Bala Krishna Juluri, Justin Hallas, Phillip Layton, Michael Fennel, Shawn Meade
  • Patent number: 8080367
    Abstract: Anti-cancer drugs are identified by screening for agents and compounds which inhibit the binding of HSP90 and IP6K2. In vitro and in vivo assays can be used. Any phenomenon associated with the binding or inhibition can be monitored, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: December 20, 2011
    Assignee: The Johns Hopkins University
    Inventors: Solomon H. Snyder, Anutosh Chakraborty, Michael Koldobskiy, Katherine Sixt, Krishna Juluri, Asif K Mustafa, Damian B Van Rossum, Randen L Patterson
  • Publication number: 20100129806
    Abstract: Anti-cancer drugs are identified by screening for agents and compounds which inhibit the binding of HSP90 and IP6K2. In vitro and in vivo assays can be used. Any phenomenon associated with the binding or inhibition can be monitored, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
    Type: Application
    Filed: December 11, 2007
    Publication date: May 27, 2010
    Applicant: The Johns Hopkins University
    Inventors: Solomon H. Snyder, Anutosh Chakraborty, Michael Koldobskiy, Katherine Sixt, Krishna Juluri, Asif K. Mustafa, Damian B. Van Rossum, Randen L. Patterson